|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Investigating the value of abatacept in the treatment of rheumatoid arthritis: a systematic review of cost-effectiveness studies显示文摘 | Athanasakis K Petrakis I Kyriopoulos J | 2013 | ISRN Rheuma- tology2013，2013，25： | 1 |
| 2 | The effect of total and anterior partial fundoplication on antireflux mechanisms of the gastroesophageal junction显示文摘 | Chrysos E Athanasakis B Pechliyanides G | 2004 | Am J Surg2004，188，1： | 1 |
| 3 | The effect of total and anterior partial fundoplication on antireflux mechanisms of the gastroesophageal junction 显示文摘 | Chrysos E Athanasakis E Pechlivanides G | 2004 | Am J Surg2004，188，1： | 1 |
| 4 | High-throughput genotyping robot-assisted method for mutation detection in patients with hypertrophic cardiomyopathy显示文摘 | Bortot B Athanasakis E Brun F | 2011 | Diagn Mol Pathol2011，20，： | 1 |
| 5 | Prospective randomized trial comparing Nissen to Nissen-Rossetti technique for laparoscopic fundoplication显示文摘 | Emmanuel Chrysos Anastasios Tzortzinis John Tsiaoussis Helias Athanasakis John-Sophocles Vasssilakis Evaghelos Xynos | 2001 | The American Journal of Surgery2001，，3： | 1 |
| 6 | Pancreatic trauma in the adult:current knowledge in diagnosis and management显示文摘 | Chrysos E Athanasakis E Xynos E | 2002 | Pancreatology2002，2，4： | 1 |
| 7 | Study ondetection for the defects of XLPE cable lines 显示文摘 | Tsalapati K Athanasakis K Pavi E et a l | 1996 | IEEE Transactions on Power Delivery1996，11，： | 1 |
| 8 | Factors affecting esoph-ageal motility in gastroeso phageal reflux disease显示文摘 | Chrysos E Prokopakis G Athanasakis E | 2003 | Arch Surg2003，138，3： | 1 |
| 9 | Posacon- azole vs fluconazole/itraconazole in the prophylaxis of invasive fungal infections in immunocompromised patients: A cost-effectiveness analysis in Greece 显示文摘 | ATHANASAKIS K PETRAKIS I KYRIOPOULOS J | 2013 | J Med Econ2013，16，5： | 1 |
| 10 | Pancreatic Trauma in the Adult:Current Knowledge in Diagnosis and Management显示文摘 | Emmanuel Chrysos Elias Athanasakis Evaghelos Xynos | 2002 | Pancreatology2002，2，1： | 1 |
| 11 | Factors affecting esophageal motility in gastroesophageal reflux disease显示文摘 | Prokopakis G Athanasakis E | 2003 | Arch Surg2003，138，3： | 1 |
| 12 | Investigating the value of abatacept in the treatment of rheumatoid arthritis: a systematic review of cost-effectiveness studies显示文摘 | Athanasakis K | 2013 | ISRN Rheumatology2013，2013，25： | 1 |
| 13 | The effect of total and anterior partial fundoplication on antireflux mechanisms of the gastroesophageal junction显示文摘 | Chrysos E Athanasakis B Pechlivanides G | 2004 | Am J Surg2004，188，1： | 1 |
| 14 | Stapled Transanal Rectal Resection (Starr) to Reverse the Anatomic Disorders of Pelvic Floor Dyssynergia显示文摘 | George Pechlivanides John Tsiaoussis Elias Athanasakis Nikolaos Zervakis Nikolaos Gouvas George Zacharioudakis Evaghelos Xynos | 2007 | World Journal of Surgery2007，，6： | 1 |
| 15 | Economic evaluation of the hepatitis C elimination strategy in Greece in the era of affordable direct-acting antivirals显示文摘BACKGROUND Hepatitis C virus(HCV) is a leading cause of worldwide liver-related morbidity and mortality. The World Health Organization released an integrated strategy targeting HCV-elimination by 2030. This study aims to estimate the required interventions to achieve elimination using updated information for direct-acting antiviral(DAA) treatment coverage, to compute the total costs(including indirect/societal costs) of the strategy and to identify whether the elimination strategy is cost-effective/cost-saving in Greece.AIM To estimate the required interventions and subsequent costs to achieve HCV elimination in Greece.METHODS A previously validated mathematical model was adapted to the Greek HCVinfected population to compare the outcomes of DAA treatment without the additional implementation of awareness or screening campaigns versus an HCV elimination strategy, which includes a sufficient number of treated patients. We estimated the total costs(direct and indirect costs), the disability-adjusted life years and the incremental cost-effectiveness ratio using two different price scenarios.RESULTS Without the implementation of awareness or screening campaigns,approximately 20000 patients would be diagnosed and treated with DAAs by2030. This strategy would result in a 19.6% increase in HCV-related mortality in2030 compared to 2015. To achieve the elimination goal, 90000 patients need to be treated by 2030. Under the elimination scenario, viremic cases would decrease by78.8% in 2030 compared to 2015. The cumulative direct costs to eliminate the disease would range from 2.1-2.3 billion euros(€) by 2030, while the indirect costs would be €1.1 billion. The total elimination cost in Greece would range from €3.2-3.4 billion by 2030. The cost per averted disability-adjusted life year is estimated between €10100 and €13380, indicating that the elimination strategy is very costeffective. Furthermore, HCV elimination strategy would save €560-895 million by2035.CONCLUSION Without large screening programs, elimination of HCV cannot be achieved. The HCV elimination strategy is feasible and cost-saving despite the uncertainty of the future cost of DAAs in Greece. | Ilias Gountas Vana Sypsa George Papatheodoridis Kyriakos Souliotis Kostas Athanasakis Homie Razavi Angelos Hatzakis | 2019 | World Journal of Gastroenterology2019，25，11： | 1 |
| 16 | The effect of total and anterior partial fundoplication on antireflux mechanisms of the gastroesophageal junction显示文摘 | Chrysos E Athanasakis E Pechlivanides G | 2004 | Am J Surg2004，188，1： | 1 |
| 17 | Stapled transanal rectal resection(STARR) to reverse the anatomic disorders of pelvic floor dyssynergia显示文摘 | Pechlivanides G Tsiaoussis J Athanasakis E | 2007 | World J Surg2007，31，6： | 1 |
| 18 | F402L variant in NLRP12 in subjects with undiagnosed periodic fevers and in healthy controls显示文摘 | De Pieri C Vuch J Athanasakis E | 2014 | Clin Exp Rheumatol2014，32，： | 1 |
| 19 | Factors af - fecting esophageal motility in gastroesophageal reflux disease 显示文摘 | Chrysos E Prokopakis G Athanasakis E Pechlivanides G Tsi- aoussis J Mantides A Xynos E | 2003 | Arch Surg2003，138，3： | 1 |
| 20 | The effect of total and anterior partial fundoplieation on antireflux mechanisms of the gastroesophageal junction显示文摘 | Chrysos E Athanasakis B Pechlivanides G et aL | 2004 | Am J Surg2004，188，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员